Used as a key intermediate in the synthesis of antiviral agents, particularly in the development of nucleoside analogs targeting RNA viruses. Its structure supports selective binding to viral polymerases, making it valuable in medicinal chemistry for designing inhibitors. The hydroxymethyl and pyrrolidine groups enhance solubility and bioavailability, which are critical for oral drug formulations. Commonly employed in research for optimizing drug candidates against hepatitis C and related viral infections.